
Obama stated not long ago that medicine has become more of a “business than a calling.” I could not disagree more with that statement. Medicine has remained a calling for many, but with the salary cuts and lack of regulation of insurance companies, physicians and surgeons have been forced to run a business. Obama has misinterpreted the situation. If you have read my previous posts, you understand that attending medical school at this time is close to a half a million dollar investment, followed by three to six years of a salary under $45,000, followed by one to five years of a salary under $60,000. If physicians have to spend $4,000 per month paying back loans for 10 to 25 years, and insurance companies will only pay 50% of what their procedures actually cost, one can imagine that pretty soon, the physician’s private practice has to operate as a business.
This is a small digression. My purpose in mentioning Obama’s statement is that in order to make up for the extreme debt and very low net salary of private practice physicians, private practices have participated in incentives given by pharmaceutical companies. These companies provide gifts, money, and various other incentives to physicians in order to ensure that their product is used. Often the drug companies will give significant monetary benefits for physicians to push the use of their product, and to push the drug over other, cheaper drugs that are essentially the same.
A law passed this summer in Vermont has set out to ban that practice. It is certainly for the benefit of the patients and their wallets to do so (and the physicians can only hope that reform comes soon so that they can stop taking all the hits when it comes to health care reform). The law, which was signed on June 8th, “bans gifts to physicians from manufacturers of prescription drugs, medical devices, and biologic products, with few exceptions.” These exceptions “include the provision of drug samples for free distribution to patients, the short-term loan of medical devices to permit their evaluation, and the distribution of journal articles and other items ‘that serve a genuine educational function.’”
What all of this really means is that Vermont has taken the first real step forward in an effort to reform the health care system. Perhaps Obama can learn from this, in that we do not necessarily have to change the entire health care system in one giant leap; we can chip away at it by ridding of the small but numerous abuses of the system.
4jcxr2diyn
Tags: access to health care, Health, health care, pharmaceutical companies, pharmaceutical market, Vermont


